The expression values of VEGFA from GSE9128 in the control group were higher compared to the Ischemic cardiomyopathy (ICM) group, coincident with early research that increased the expression of VEGFA might be a potential therapeutic method for ICM [26]. Here, VEGFA is linked to ischemic cardiomyopathy.